Oncostatin M (OSM) protects against cardiac ischaemia/reperfusion injury in diabetic mice by regulating apoptosis, mitochondrial biogenesis and insulin sensitivity
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncostatin M (OSM) protects against cardiac ischaemia/reperfusion injury in diabetic mice by regulating apoptosis, mitochondrial biogenesis and insulin sensitivity
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 19, Issue 6, Pages 1296-1307
Publisher
Wiley
Online
2015-03-09
DOI
10.1111/jcmm.12501
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction
- (2014) Zheng Zhang et al. BASIC RESEARCH IN CARDIOLOGY
- Mitochondrial Dysfunction as an Arrhythmogenic Substrate
- (2013) David Montaigne et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Perspectives and Potential Applications of Mitochondria-Targeted Antioxidants in Cardiometabolic Diseases and Type 2 Diabetes
- (2013) Milagros Rocha et al. MEDICINAL RESEARCH REVIEWS
- Oxidative Stress and Mitochondrial Dysfunction in Type 2 Diabetes
- (2012) Victor M. Victor et al. CURRENT PHARMACEUTICAL DESIGN
- Effect of autologous bone marrow mononuclear cells transplantation in diabetic patients with ST-segment elevation myocardial infarction
- (2012) Dongdong Sun et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Metabolic homeostasis of the heart: Figure 1.
- (2012) Robert S. Balaban JOURNAL OF GENERAL PHYSIOLOGY
- Luteolin Limits Infarct Size and Improves Cardiac Function after Myocardium Ischemia/Reperfusion Injury in Diabetic Rats
- (2012) Dongdong Sun et al. PLoS One
- Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3beta dependent pathway in experimental diabetic cardiomyopathy
- (2011) Dongdong Sun et al. Cardiovascular Diabetology
- Oncostatin M Is a Major Mediator of Cardiomyocyte Dedifferentiation and Remodeling
- (2011) Thomas Kubin et al. Cell Stem Cell
- Mitochondrial Dysfunction and Targeted Drugs: A Focus on Diabetes
- (2011) Victor M Victor et al. CURRENT PHARMACEUTICAL DESIGN
- Prolonged overcirculation-induced pulmonary arterial hypertension as a cause of right ventricular failure
- (2011) B. Rondelet et al. EUROPEAN HEART JOURNAL
- Inositol Pyrophosphates Inhibit Akt Signaling, Thereby Regulating Insulin Sensitivity and Weight Gain
- (2010) Anutosh Chakraborty et al. CELL
- Activation of Akt/GSK-3β signaling pathway is involved in intermedin1–53 protection against myocardial apoptosis induced by ischemia/reperfusion
- (2009) Jun-Qiu Song et al. APOPTOSIS
- Tanshinone IIA pretreatment protects myocardium against ischaemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway in diabetic rats
- (2009) Y. Zhang et al. DIABETES OBESITY & METABOLISM
- Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up
- (2009) F. Cao et al. EUROPEAN HEART JOURNAL
- The inflammatory mediator oncostatin M induces stromal derived factor-1 in human adult cardiac cells
- (2008) P. J. Hohensinner et al. FASEB JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More